# HCW Biologics Inc.: Form 8-K, filed Nov 19, 2025

- Company: [HCW Biologics Inc.](/companies/hcwb.md) (CIK 1828673)
- Form: 8-K
- Filed: 2025-11-19
- Accepted by EDGAR: Nov 18, 2025, 20:25 ET
- Period: 2025-11-17
- Accession: 0001193125-25-286642
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1828673/000119312525286642/hcwb-20251117.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1828673/000119312525286642/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1828673/000119312525286642/hcwb-20251117.htm

Filed Nov 19, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-286642. Last ingested by Listed: Nov 5, 2026, 12:33 ET. No prices; not investment advice.